step 11 semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Semaglutide trial shows 16% weight

Ozempic is a subcutaneous injection, meaning the needle should reach the fat tissue just beneath the skin not muscle

Regular check-ins offer reassurance, help adjust your plan if needed, and ensure youre ready for your next treatment phase confidently

doi: 10.1007/s11033-012-1961-9

doi: 10.1093/advances/nmy067

Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, et al

First-time AOM semaglutide prescribing increased by over 50%, marking the largest quarter-over-quarter increase in first-time AOM semaglutide prescribing since mid-2024, likely driven by the approval of the oral formulation of Wegovy in December 2025